Pharmaceuticals
Pfizer to acquire cancer drug maker Array Biopharma for $10.6 bn
18 Jun 2019
Array’s Braftovi and Mektovi, launched last July for the deadliest form of skin cancer at a price of $22,000 per month, had sales of around $72 million over their first nine months, besides revenue from royalty and licensing deals
CCI approves GSK-Pfizer consumer healthcare JV
24 May 2019
And now, formaldehyde found in J&J’s baby shampoo
01 Apr 2019
Johnson & Johnson is facing regulatory scrutiny over most of its products, including its baby care products, over health concerns
